Suspended NA INTERVENTIONAL 1-arm NCT01519297

Preeclampsia: A Marker for Future Cardiovascular Risk in Women

Sponsor: Brigham and Women's Hospital

Conditions Preeclampsia Pregnancy Induced Hypertension

Interventions Irbesartan

Updated 6 times since 2017 Last updated: Jan 15, 2019 Started: May 31, 2012 Primary completion: Jul 31, 2017 Completion: Jul 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Suspended

Pending funding

A NA clinical study on Preeclampsia and Pregnancy Induced Hypertension, this trial is suspended. The trial is conducted by Brigham and Women's Hospital and has accumulated 6 data snapshots since 2012. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Suspended NA
Jul 2024 — Sep 2024 [monthly]

Suspended NA
Jan 2021 — Jul 2024 [monthly]

Suspended NA
Feb 2019 — Jan 2021 [monthly]

Suspended NA

Status: Recruiting → Suspended
Jun 2018 — Feb 2019 [monthly]

Recruiting NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Recruiting NA

First recorded

May 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Brigham and Women's Hospital

Data source: Brigham and Women's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States